P

Inventor

YAN LIANG ZENG

US11 patents
⚠️ This page may combine multiple inventors who share the name “YAN LIANG ZENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

COHBAR INC

3 patents
US11111271B2Sep 7, 2021

Therapeutic peptides

COHBAR INC6 citations79
US11332497B2May 17, 2022

Therapeutic peptides

COHBAR INC1 citations57
US11753445B2Sep 12, 2023

Therapeutic peptides

COHBAR INC0 citations54

MAINLINE BIOSCIENCES LLC

2 patents
US11123437B2Sep 21, 2021

Selective CXCR4 binding peptide conjugate and methods for making and using the same

MAINLINE BIOSCIENCES LLC4 citations68
US10639379B2May 5, 2020

High affinity CXCR4 selective binding conjugate and method for using the same

MAINLINE BIOSCIENCES LLC3 citations68

Mainline Biosciences

2 patents
US10870681B2Dec 22, 2020

CXCR4 antagonists and methods of use

Mainline Biosciences2 citations68
US10351601B2Jul 16, 2019

CXCR4 antagonists and methods of use

Mainline Biosciences4 citations68

LILLY CO ELI

2 patents
USRE42274EApr 5, 2011

Cyclic peptide CXCR4 antagonists

LILLY CO ELI3 citations60
US7691813B2Apr 6, 2010

Cyclic peptide CXCR4 antagonists

LILLY CO ELI0 citations49

MAINLINE BIOSCIENCES SHANGHAI CO LTD

2 patents
US11883501B2Jan 30, 2024

Selective CXCR4 binding peptide conjugate and methods for making and using the same

MAINLINE BIOSCIENCES SHANGHAI CO LTD0 citations54
US11771736B2Oct 3, 2023

Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same

MAINLINE BIOSCIENCES SHANGHAI CO LTD0 citations44